Biotechnology Daily
more-
Roche welcomes PathAI into its open digital pathology initiative
Roche has tapped PathAI for a collaboration that looks to merge artificial intelligence programs with…
Industry vets launch Tentarix with $50M to develop antibody-based cancer-killing treatments
Resilience commits $30M to launch new biotechs out of Harvard with focus on therapeutics, biomanufacturing
Exscientia AI study spots which blood cancer therapies work and which don’t
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in mice
Market Watch
more-
Weekly Market Review – October 23, 2021
Stock Markets Making significant moves to record highs in the past trading week are the…
Bio Business News
more
Biogen’s ALS drug has failed phase 3. Will FDA approve anyway?
Stop me if you think you’ve heard this one before.…
Medtronic to leap ahead in diabetes race with $300M Triple Jump purchase: report
Amid back-to-back expansions of two Class I recalls pertaining to…
Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite
Kojin Therapeutics likes to do things differently: Its platform is…
World News
more
Stocks close with a round of records, Dow clinches 35,000
U.S. stocks swept to another round of records Monday as…
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Weekly Market Review – October 23, 2021
Roche welcomes PathAI into its open digital pathology initiative
Industry vets launch Tentarix with $50M to develop antibody-based cancer-killing treatments
Resilience commits $30M to launch new biotechs out of Harvard with focus on therapeutics, biomanufacturing
Exscientia AI study spots which blood cancer therapies work and which don’t
Biogen’s ALS drug has failed phase 3. Will FDA approve anyway?
Medtronic to leap ahead in diabetes race with $300M Triple Jump purchase: report
Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite
Hologic dreams bigger for Bolder Surgical with $160M acquisition deal
Virgin Galactic Holdings Inc. stock remains steady Thursday, underperforms market